|
SCAMP2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.119700E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.730500E-02 |
| Normal-vs-Stage2 |
9.576300E-03 |
| Normal-vs-Stage3 |
5.83210000000278E-05 |
| Normal-vs-Stage4 |
3.109900E-02 |
| Stage1-vs-Stage2 |
6.788100E-02 |
| Stage1-vs-Stage3 |
1.196120E-03 |
| Stage1-vs-Stage4 |
2.148800E-01 |
| Stage2-vs-Stage3 |
6.027600E-01 |
| Stage2-vs-Stage4 |
7.615600E-01 |
| Stage3-vs-Stage4 |
3.976000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.119760E-03 |
| Normal-vs-AfricanAmerican |
3.293800E-01 |
| Normal-vs-Asian |
2.976800E-01 |
| Caucasian-vs-AfricanAmerican |
2.877200E-01 |
| Caucasian-vs-Asian |
9.248600E-01 |
| AfricanAmerican-vs-Asian |
7.783600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.68029999999742E-05 |
| Normal-vs-Female |
5.725000E-01 |
| Male-vs-Female |
6.05309999999193E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.081500E-03 |
| Normal-vs-Age(41-60Yrs) |
4.438100E-02 |
| Normal-vs-Age(61-80Yrs) |
1.262360E-03 |
| Normal-vs-Age(81-100Yrs) |
2.004600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.764400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.814850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.518400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.083800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.748800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.412200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.043200E-01 |
| Normal-vs-Grade 2 |
6.591700E-02 |
| Normal-vs-Grade 3 |
2.981900E-03 |
| Normal-vs-Grade 4 |
2.78689999999582E-06 |
| Grade 1-vs-Grade 2 |
8.603500E-02 |
| Grade 1-vs-Grade 3 |
4.744400E-02 |
| Grade 1-vs-Grade 4 |
1.046250E-02 |
| Grade 2-vs-Grade 3 |
1.738170E-01 |
| Grade 2-vs-Grade 4 |
7.979500E-04 |
| Grade 3-vs-Grade 4 |
1.745530E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.603400E-01 |
| Normal-vs-ccB subtype |
3.52459994523713E-09 |
| ccA subtype-vs-ccB subtype |
3.88111764948462E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.642480E-02 |
| Normal-vs-N1 |
6.417000E-01 |
| N0-vs-N1 |
6.929600E-01 |
|
|
